Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized Therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized Therapy
Authors
Keywords
Xenograft, Hepatocellular Carcinoma, Multikinase Inhibitors
Journal
Cellular and Molecular Gastroenterology and Hepatology
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-12-17
DOI
10.1016/j.jcmgh.2020.12.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Establishment and Preclinical Therapy of Patient-derived Hepatocellular Carcinoma Xenograft Model
- (2020) Yuwei Wu et al. IMMUNOLOGY LETTERS
- Establishment of a hepatocellular carcinoma patient‐derived xenograft platform and its application in biomarker identification
- (2019) Bo Hu et al. INTERNATIONAL JOURNAL OF CANCER
- A global view of hepatocellular carcinoma: trends, risk, prevention and management
- (2019) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- A murine model demonstrating reversal of structural and functional correlates of cirrhosis with progenitor cell transplantation
- (2019) Mark D. Muthiah et al. Scientific Reports
- PDXliver: a database of liver cancer patient derived xenograft mouse models
- (2018) Sheng He et al. BMC CANCER
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Molecular therapies and precision medicine for hepatocellular carcinoma
- (2018) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
- (2018) Giorgia Marisi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Vessels that encapsulate tumor clusters (VETC) pattern is a predictor of sorafenib benefit in patients with hepatocellular carcinoma
- (2018) Jian-Hong Fang et al. HEPATOLOGY
- Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy
- (2017) Maryam Tahmasebi Birgani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
- (2017) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection
- (2017) Maneerat Chayanupatkul et al. JOURNAL OF HEPATOLOGY
- Effect of Background Liver Cirrhosis on Outcomes of Hepatectomy for Hepatocellular Carcinoma
- (2017) Kazunari Sasaki et al. JAMA Surgery
- In vitro three dimensional culture of hepatocellular carcinoma to measure prognosis and responsiveness to chemotherapeutic agents
- (2016) Brad Shrum et al. HEPATOBILIARY SURGERY AND NUTRITION
- An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis
- (2015) Thomas Reiberger et al. Nature Protocols
- Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development
- (2015) Qingyang Gu et al. Oncotarget
- Prognostic Value of VEGF in Hepatocellular Carcinoma Patients Treated with Sorafenib: A Meta-Analysis
- (2015) Guangchao Cao et al. MEDICAL SCIENCE MONITOR
- Lessons from patient-derived xenografts for better in vitro modeling of human cancer
- (2014) Stephen Yiu Chuen Choi et al. ADVANCED DRUG DELIVERY REVIEWS
- VEGF Signaling in Cancer Treatment
- (2014) Daniela Sia et al. CURRENT PHARMACEUTICAL DESIGN
- Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development
- (2014) Thomas Tu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
- (2013) Virginia Hernandez–Gea et al. GASTROENTEROLOGY
- Tumour size and differentiation predict survival after liver resection for hepatocellular carcinoma arising from non-cirrhotic and non-fibrotic liver: A case-controlled study
- (2013) V.S. Yip et al. International Journal of Surgery
- Novel roles of liver sinusoidal endothelial cell lectin in colon carcinoma cell adhesion, migration and in-vivo metastasis to the liver
- (2012) Yunfei Zuo et al. GUT
- Safety and Efficacy of Sorafenib in Patients With Advanced Hepatocellular Carcinoma in Consideration of Concomitant Stage of Liver Cirrhosis
- (2009) Marcus Alexander Wörns et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
- (2008) Yujin Hoshida et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation